Robert P. Lenk's most recent trade in Plus Therapeutics Inc was a trade of 110,000 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Plus Therapeutics Inc | Robert P. Lenk | Director | Purchase of securities on an exchange or from another person at price $ 0.49 per share. | 22 Aug 2025 | 110,000 | 139,327 (3%) | 2% | 0.5 | 53,779 | Common Stock |
| Plus Therapeutics Inc | Robert P. Lenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 297,794 | 297,794 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Robert P. Lenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 40,122 | 40,122 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Robert P. Lenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 3,650 | 3,650 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Robert P. Lenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 8,334 | 8,334 | - | - | Warrants (Right to buy) | |
| Plus Therapeutics Inc | Robert P. Lenk | Director | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 08 May 2024 | 4,167 | 29,327 (0%) | 0% | 2.0 | 8,501 | Common Stock |
| Plus Therapeutics Inc | Lenk P. Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 2,250 | 2,250 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Robert P. Lenk | Director | Sale of securities on an exchange or to another person at price $ 0.31 per share. | 30 Dec 2022 | 1,500 | 8,500 (0%) | 0% | 0.3 | 472 | Common Stock |
| Plus Therapeutics Inc | Robert P. Lenk | Director | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 13 Sep 2021 | 7,000 | 10,000 (0%) | 0% | 1.9 | 13,011 | Common Stock |
| Plus Therapeutics Inc | Robert P. Lenk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 6,336 | 6,336 | - | - | Stock Option (Right to Buy) |